MT1F | OmnibusX

Name	Number of supported studies	Average coverage
epithelial cell	11 studies	48% ± 19%	Explore
CD8-positive, alpha-beta T cell	8 studies	19% ± 3%	Explore
epithelial cell of proximal tubule	7 studies	53% ± 21%	Explore
enterocyte	7 studies	48% ± 20%	Explore
goblet cell	7 studies	43% ± 16%	Explore
kidney loop of Henle epithelial cell	6 studies	22% ± 6%	Explore
ciliated cell	6 studies	35% ± 21%	Explore
classical monocyte	5 studies	19% ± 2%	Explore
kidney distal convoluted tubule epithelial cell	5 studies	31% ± 9%	Explore
progenitor cell	5 studies	41% ± 16%	Explore
astrocyte	5 studies	40% ± 24%	Explore
intestinal crypt stem cell	4 studies	53% ± 24%	Explore
abnormal cell	4 studies	22% ± 3%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	20% ± 2%	Explore
CD8-positive, alpha-beta memory T cell	3 studies	30% ± 12%	Explore
type B pancreatic cell	3 studies	34% ± 7%	Explore
exhausted T cell	3 studies	25% ± 3%	Explore
enteroendocrine cell	3 studies	36% ± 18%	Explore
transit amplifying cell	3 studies	44% ± 18%	Explore
T cell	3 studies	22% ± 3%	Explore
Mueller cell	3 studies	48% ± 25%	Explore
acinar cell	3 studies	24% ± 8%	Explore
luminal cell of prostate epithelium	3 studies	29% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	19% ± 3%	Explore
hepatocyte	3 studies	62% ± 34%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
pancreas	100%	1743.09	327 / 328	97%	35.69	173 / 178
brain	99%	1422.87	2627 / 2642	93%	40.17	658 / 705
thymus	100%	7146.14	652 / 653	90%	182.65	544 / 605
prostate	91%	1279.47	222 / 245	93%	68.89	466 / 502
kidney	100%	6171.65	89 / 89	75%	32.79	673 / 901
breast	83%	378.03	381 / 459	72%	15.23	800 / 1118
adrenal gland	100%	1325.30	258 / 258	54%	48.81	125 / 230
stomach	81%	1153.55	291 / 359	71%	15.91	203 / 286
liver	99%	6425.01	223 / 226	47%	45.31	192 / 406
lung	51%	206.40	293 / 578	69%	14.26	800 / 1155
intestine	42%	324.41	402 / 966	69%	17.04	361 / 527
ovary	6%	19.48	10 / 180	97%	79.53	417 / 430
spleen	99%	504.32	238 / 241	0%	0	0 / 0
skin	27%	77.02	484 / 1809	62%	15.09	292 / 472
bladder	29%	79.90	6 / 21	57%	13.82	285 / 504
lymph node	0%	0	0 / 0	83%	27.55	24 / 29
adipose	81%	626.89	974 / 1204	0%	0	0 / 0
uterus	9%	26.19	16 / 170	71%	18.56	327 / 459
esophagus	14%	50.36	209 / 1445	64%	15.88	118 / 183
eye	0%	0	0 / 0	57%	10.28	46 / 80
tonsil	0%	0	0 / 0	53%	10.39	24 / 45
peripheral blood	32%	145.74	296 / 929	0%	0	0 / 0
blood vessel	31%	128.53	419 / 1335	0%	0	0 / 0
heart	7%	21.23	62 / 861	0%	0	0 / 0
muscle	2%	8.22	16 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

GO_0071294	Biological process	cellular response to zinc ion
GO_0071276	Biological process	cellular response to cadmium ion
GO_0071280	Biological process	cellular response to copper ion
GO_0010273	Biological process	detoxification of copper ion
GO_0045926	Biological process	negative regulation of growth
GO_0006882	Biological process	intracellular zinc ion homeostasis
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding
GO_0008270	Molecular function	zinc ion binding
GO_0046872	Molecular function	metal ion binding

Gene name	MT1F
Protein name	Metallothionein Metallothionein-1F (MT-1F) (Metallothionein-IF) (MT-IF)
Synonyms	PRO0376
Description	FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. .
Accessions	ENST00000334350.7 ENST00000568475.1 P04733 H3BRY8

MT1F report